Why patients with triple negative breast cancer respond differently to treatment. – The Institute of Cancer Research

The Institute of Cancer Research, made the following remark on Twitter:

“Our scientists have looked into better understanding why patients with triple negative breast cancer respond differently to treatment, in a new study run by The Institute of Cancer Research Clinical Trials and Statistics Unit.

The findings could help accelerate the development of more personalised treatments.”

For full article: Click here
Source: The Institute of Cancer Research / Twitter